Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.8400
-0.1350
(-6.84%)
At close: April 4 at 4:00:02 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.79 | -0.67 | -0.48 | -0.09 |
| EPS Actual | -0.73 | -0.66 | -0.65 | -- |
| Difference | 0.06 | 0.01 | -0.17 | -- |
| Surprise % | 7.59% | 1.49% | -35.42% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IKT | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/28/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 2/12/2025 |
| Initiated | Jefferies: Buy | 11/8/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 10/14/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/21/2024 |
Related Tickers
DSGN Design Therapeutics, Inc.
3.4000
-3.41%
UPB Upstream Bio, Inc.
6.10
-3.17%
COYA Coya Therapeutics, Inc.
5.45
-10.66%
TRML Tourmaline Bio, Inc.
12.83
-2.21%
PCSA Processa Pharmaceuticals, Inc.
0.3400
+6.75%
AVTX Avalo Therapeutics, Inc.
5.80
-11.99%
DBVT DBV Technologies S.A.
6.50
-17.30%
ENTO Entero Therapeutics, Inc.
0.5090
+16.48%
CNTX Context Therapeutics Inc.
0.5991
-16.68%
MLYS Mineralys Therapeutics, Inc.
12.40
-8.35%